Osteonecrosis in the era of Gaucher disease therapies

被引：0
|
作者：
Basiri, Mohsen [1 ]
Ruan, Jiapeng [2 ]
Belinsky, Glenn [3 ]
Yang, Ruhua [4 ]
Guo, Lilu [5 ]
Klinger, Katherine W. [6 ]
Mistry, Pramod K. [7 ]
机构：
[1] Yale Sch Med, Internal Med, New Haven, CT USA
[2] Yale Univ, Internal Med Dept, Med Sch, New Haven, CT USA
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Internal Med, Sch Med, New Haven, CT USA
[5] Sanofi, Translat Sci, Framingham, MA USA
[6] Sanofi, R&D, Framingham, MA USA
[7] Yale Univ, Dept Pediat GI Hepatol, Sch Med, New Haven, CT USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2022.107020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
37
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [1] Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center
    Basiri, Mohsen
    Ghaffari, Mohammad E.
    Ruan, Jiapeng
    Murugesan, Vagishwari
    Kleytman, Nathaniel
    Belinsky, Glenn
    Akhavan, Amir
    Lischuk, Andrew
    Guo, Lilu
    Klinger, Katherine
    Mistry, Pramod K.
    ELIFE, 2023, 12
  • [2] Potential biomarkers of osteonecrosis in Gaucher disease
    Pavlova, Elena V.
    Deegan, Patrick B.
    Tindall, Jane
    McFarlane, Ian
    Mehta, Atul
    Hughes, Derralyn
    Wraith, J. Edmond
    Cox, Timothy M.
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 46 (01) : 27 - 33
  • [3] Simultaneous Bilateral Femoral Osteonecrosis in Gaucher Disease
    Cohen, Daniel
    Levy, Yadin
    Bar-Ziv, Yaron
    Revel-Vilk, Shoshana
    Zimran, Ari
    Lebel, Ehud
    LIFE-BASEL, 2023, 13 (05):
  • [4] Gaucher's disease in the lipidomics era
    Fuller, Maria
    CLINICAL LIPIDOLOGY, 2012, 7 (04) : 431 - 441
  • [5] Avascular Osteonecrosis in Untreated Patients with Type 1 Gaucher Disease
    Mistry, Pramod K.
    Deegan, Patrick
    Vellodi, Ashok
    Cole, J. Alexander
    Yeh, Michael
    Weinreb, Neal J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S118 - S118
  • [6] Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacement
    Lebel, E
    Elstein, D
    Hain, D
    Hadas-Halpern, I
    Zimran, A
    Itzchaki, M
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (08): : 595 - 596
  • [7] Gaucher disease presenting with vertebral compression fractures and vertebral osteonecrosis
    Clinckemaillie, G.
    Larbi, A.
    Omoumi, P.
    Manelfe, J.
    Dallaudiere, B.
    JBR-BTR, 2015, 98 (01): : 50 - 50
  • [8] Development of Novel Therapies in Murine Models for Gaucher Disease
    Karlsson, Stefan
    HUMAN GENE THERAPY, 2010, 21 (04) : 490 - 491
  • [9] Development of Novel Therapies in Murine Models for Gaucher Disease
    Enquist, Ida Berglin
    Nilsson, Eva
    Lo Bianco, Christophe
    Mansson, Jan-Eric
    Ehinger, Mats
    Brady, Roscoe O.
    Richter, Johan
    Karlsson, Stefan
    CLINICAL THERAPEUTICS, 2009, 31 : S198 - S199
  • [10] Risk factors for osteonecrosis in patients with type 1 Gaucher's disease
    Rodrigue, SW
    Rosenthal, DI
    Barton, NW
    Zurakowski, D
    Mankin, HJ
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1999, (362) : 201 - 207
12345